Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) EPS (Basic) (2019 - 2026)

Profound Medical has reported EPS (Basic) over the past 7 years, most recently at $0.27 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 86.81% year-over-year to $0.27; the TTM value through Dec 2025 reached $1.41, down 27.64%, while the annual FY2025 figure was $1.41, 25.89% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.27 at Profound Medical, up from $0.26 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $2.05 in Q4 2024 and troughed at -$61.43 in Q4 2022.
  • A 5-year average of -$3.08 and a median of $0.03 in 2021 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): plummeted 89252.15% in 2024 and later surged 1834.9% in 2025.
  • Year by year, EPS (Basic) stood at -$2.45 in 2021, then plummeted by 2402.84% to -$61.43 in 2022, then skyrocketed by 96.33% to -$2.25 in 2023, then skyrocketed by 190.84% to $2.05 in 2024, then plummeted by 86.81% to $0.27 in 2025.
  • Business Quant data shows EPS (Basic) for PROF at $0.27 in Q4 2025, $0.26 in Q3 2025, and $0.52 in Q2 2025.